DONNELLE STORRS: Open Payments
NPI 1053879742 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$460 in 12 payments from 5 companies in 2025. Trend: 2023 $124 · 2024 $125 · 2025 $460
Food & beverage: $460
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 5 | $180 |
| Madrigal Pharmaceuticals | 2 | $162 |
| Novo Nordisk Inc | 2 | $61 |
| ORPHALAN INC | 2 | $37 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
Products named: REZDIFFRA, Livdelzi, Wegovy, CUVRIOR, XIFAXAN.
Industry payments across TX — which companies pay providers there.
